HK1018059A1 - Tetrahydroimidazo (2,1-A) isoquinoline derivatives. - Google Patents

Tetrahydroimidazo (2,1-A) isoquinoline derivatives.

Info

Publication number
HK1018059A1
HK1018059A1 HK99102885A HK99102885A HK1018059A1 HK 1018059 A1 HK1018059 A1 HK 1018059A1 HK 99102885 A HK99102885 A HK 99102885A HK 99102885 A HK99102885 A HK 99102885A HK 1018059 A1 HK1018059 A1 HK 1018059A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydroimidazo
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
HK99102885A
Other languages
English (en)
Inventor
Dirk Leysen
Gerardus Stephanus Franc Ruigt
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1018059A1 publication Critical patent/HK1018059A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK99102885A 1997-06-26 1999-07-06 Tetrahydroimidazo (2,1-A) isoquinoline derivatives. HK1018059A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201950 1997-06-26

Publications (1)

Publication Number Publication Date
HK1018059A1 true HK1018059A1 (en) 1999-12-10

Family

ID=8228485

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99102885A HK1018059A1 (en) 1997-06-26 1999-07-06 Tetrahydroimidazo (2,1-A) isoquinoline derivatives.

Country Status (27)

Country Link
US (1) US5994366A (xx)
EP (1) EP0887349B1 (xx)
JP (1) JP4339939B2 (xx)
KR (1) KR100540317B1 (xx)
CN (1) CN1139589C (xx)
AR (1) AR013132A1 (xx)
AT (1) ATE209649T1 (xx)
AU (1) AU737924B2 (xx)
BR (1) BR9802286A (xx)
CA (1) CA2241469C (xx)
CZ (1) CZ293265B6 (xx)
DE (1) DE69802624T2 (xx)
DK (1) DK0887349T3 (xx)
ES (1) ES2169471T3 (xx)
HK (1) HK1018059A1 (xx)
HU (1) HUP9801451A3 (xx)
ID (1) ID20494A (xx)
IL (1) IL124914A (xx)
NO (1) NO311028B1 (xx)
NZ (1) NZ330722A (xx)
PL (1) PL190281B1 (xx)
PT (1) PT887349E (xx)
RU (1) RU2204560C2 (xx)
SG (1) SG66484A1 (xx)
TR (1) TR199801175A1 (xx)
TW (1) TW513411B (xx)
ZA (1) ZA985559B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624093A (en) * 1970-03-10 1971-11-30 American Home Prod 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols
US4100165A (en) * 1975-06-17 1978-07-11 Sandoz, Inc. Imidazo [2,1-a]isoquinolines

Also Published As

Publication number Publication date
IL124914A (en) 2000-10-31
PT887349E (pt) 2002-04-29
DE69802624D1 (de) 2002-01-10
AU737924B2 (en) 2001-09-06
KR19990007323A (ko) 1999-01-25
JPH1171373A (ja) 1999-03-16
ID20494A (id) 1998-12-31
SG66484A1 (en) 1999-07-20
CN1139589C (zh) 2004-02-25
HUP9801451A2 (hu) 1999-02-01
PL190281B1 (pl) 2005-11-30
DE69802624T2 (de) 2002-08-01
NZ330722A (en) 1999-08-30
EP0887349B1 (en) 2001-11-28
KR100540317B1 (ko) 2006-04-17
ES2169471T3 (es) 2002-07-01
CZ293265B6 (cs) 2004-03-17
JP4339939B2 (ja) 2009-10-07
CA2241469A1 (en) 1998-12-26
BR9802286A (pt) 2000-02-08
PL327053A1 (en) 1999-01-04
HU9801451D0 (en) 1998-08-28
TW513411B (en) 2002-12-11
US5994366A (en) 1999-11-30
CN1203916A (zh) 1999-01-06
DK0887349T3 (da) 2002-03-25
ATE209649T1 (de) 2001-12-15
CA2241469C (en) 2008-08-19
AU7319698A (en) 1999-01-07
NO982952L (no) 1998-12-28
NO982952D0 (no) 1998-06-25
CZ204898A3 (cs) 1999-08-11
TR199801175A1 (xx) 1999-01-18
NO311028B1 (no) 2001-10-01
EP0887349A1 (en) 1998-12-30
ZA985559B (en) 1999-01-20
RU2204560C2 (ru) 2003-05-20
IL124914A0 (en) 1999-01-26
HUP9801451A3 (en) 1999-03-29
AR013132A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
PL337057A1 (en) 2-substituted 4,5-diarylimidazoles
ZA97521B (en) 19-Nor-pregnene derivatives.
SI0921125T1 (en) 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
HK1016976A1 (en) Resorcinyl-triazine.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL134220A0 (en) 6,9-bridged erythromycin derivatives
ZA9811128B (en) 1,3,8-Triaza-spiro(4,5)decan-4-on derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
ZA989412B (en) Isoquinolines.
CY2425B1 (en) 2,4-Diaminopyrimidine derivatives.
ZA982436B (en) Thiazolimine derivatives.
HK1017834A1 (en) Bodyshaper.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
HK1018059A1 (en) Tetrahydroimidazo (2,1-A) isoquinoline derivatives.
ZA97672B (en) Tetrahydroisoquinoline derivatives.
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA981307B (en) 4-aminoethoxyindazole derivatives.
ZA953775B (en) 8-Amino-pyrido(1,2,3-D,E)(1,3,4) Benzoxadiazine derivatives
ZA98263B (en) O-fucosyltransferase.
ZA972692B (en) Pyrrolopyrrolone derivatives.
ZA977881B (en) N-benzylazolium derivatives.
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100625